NSE:AUROPHARMA
Aurobindo Pharma
- Stock
1,214.00
−1.23%
−15.10
Last Close
1,229.10
02/05 08:51
Market Cap
772.21B
Beta: 0.48
Volume Today
497.51K
Avg: 2.09M
PE Ratio
25.84
PFCF: −10,376.22
Dividend Yield
0.59%
Payout:0%
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '24 | Mar '25 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 120.43B - | 136.49B 13.34% | 146.64B 7.43% | 161.99B 10.47% | 192.26B 18.68% | 192.26B 0% | 245.58B 27.73% | 233.67B 4.85% | 233.67B 0% | 290.02B 24.12% | 290.02B 0% | 317.24B 9.39% | |
cost of revenue | 55.06B - | 61.58B 11.84% | 64.34B 4.49% | 67.53B 4.95% | 87.13B 29.02% | 87.13B 0% | 99.02B 13.66% | 101.40B 2.40% | 101.40B 0% | 180.47B 77.98% | 129.86B 28.05% | 130.26B 0.31% | |
gross profit | 65.37B - | 74.92B 14.60% | 82.30B 9.85% | 94.46B 14.79% | 105.13B 11.29% | 105.13B 0% | 146.55B 39.40% | 132.26B 9.75% | 132.26B 0% | 109.54B 17.18% | 160.16B 46.21% | 186.97B 16.74% | |
selling and marketing expenses | 9.34B - | 9.47B 1.31% | 11.30B 19.43% | 10.90B 3.56% | 11.92B 9.36% | 11.92B 0% | 16.43B 37.84% | 15.69B 4.55% | 15.69B 0% | 16.85B - | |||
general and administrative expenses | 2.65B - | 2.65B 0.07% | 3.31B 25.19% | 4.10B 23.61% | 4.25B 3.69% | 4.25B 0% | 8.27B 94.71% | 6.45B 22.03% | 6.45B 0% | 8.18B - | |||
selling general and administrative expenses | 11.99B - | 12.11B 1.04% | 14.62B 20.69% | 15.00B 2.60% | 16.17B 7.81% | 16.17B 0% | 24.70B 52.78% | 22.13B 10.40% | 22.13B 0% | 66.33B 199.67% | 40.43B 39.04% | 44.76B 10.69% | |
research and development expenses | 253M - | 150.60M 40.47% | 165.80M 10.09% | 292.20M 76.24% | 756.30M 158.83% | 756.30M 0% | 688.10M 9.02% | 652.40M 5.19% | 652.40M 0% | 15.22B - | |||
other expenses | 431.50M - | 299.50M 30.59% | 306.10M 2.20% | 803.70M 162.56% | 1.02B 26.76% | 1.02B 0% | 2.26B 121.61% | 1.35B 40.40% | 76.50B 5,584.85% | 5.19B 93.22% | |||
cost and expenses | 97.17B - | 107.85B 11.00% | 116.22B 7.76% | 129.32B 11.27% | 159.17B 23.09% | 159.17B 0% | 200.82B 26.16% | 200.69B 0.06% | 200.69B 0% | 246.81B 22.98% | 185.51B 24.83% | 175.02B 5.66% | |
operating expenses | 42.11B - | 46.28B 9.89% | 51.88B 12.10% | 61.79B 19.11% | 72.05B 16.60% | 72.05B 0% | 101.79B 41.28% | 99.28B 2.46% | 99.28B 0% | 66.33B 33.19% | 55.66B 16.09% | 44.76B 19.59% | |
interest expense | 708.60M - | 793.30M 11.95% | 545.10M 31.29% | 628.90M 15.37% | 1.51B 139.75% | 1.51B 0% | 595.70M 60.49% | 368.40M 38.16% | 368.40M 0% | 2.90B 686.40% | 2.90B 0% | 4.57B 57.83% | |
ebitda | 26.44B - | 32.18B 21.68% | 35.71B 10.99% | 38.89B 8.90% | 40.23B 3.43% | 40.23B 0% | 53.78B 33.70% | 46.21B 14.08% | 46.21B 0% | 58.43B 26.44% | 61.79B 5.75% | 66.05B 6.91% | |
operating income | 23.26B - | 28.64B 23.13% | 30.42B 6.21% | 32.67B 7.41% | 33.08B 1.26% | 33.08B 0% | 44.54B 34.61% | 33.06B 25.76% | 34.94B 5.69% | 43.21B 23.66% | 104.50B 141.83% | 142.22B 36.09% | |
depreciation and amortization | 3.33B - | 3.93B 18.04% | 4.28B 8.92% | 5.58B 30.48% | 6.68B 19.71% | 6.68B 0% | 10.55B 58.00% | 11.27B 6.74% | 11.27B 0% | 167.90K 100.00% | 14.92B 8,885,870.40% | 16.49B 10.56% | |
total other income expenses net | -1.58B - | -1.42B 10.48% | 187.20M 113.21% | -262.40M 240.17% | -2.17B 727.36% | -2.17B 0% | 28.90B 1,431.19% | 663.10M 97.71% | -1.22B 283.59% | 758.10M 162.27% | -60.70B 8,107.39% | -91.56B 50.82% | |
income before tax | 21.68B - | 27.22B 25.58% | 30.61B 12.43% | 32.41B 5.89% | 30.91B 4.62% | 30.91B 0% | 73.44B 137.55% | 33.73B 54.07% | 33.73B 0% | 43.97B 30.37% | 43.80B 0.39% | 50.66B 15.67% | |
income tax expense | 5.97B - | 7.44B 24.77% | 7.60B 2.05% | 8.18B 7.72% | 7.27B 11.17% | 7.27B 0% | 20.10B 176.50% | 7.26B 63.89% | 7.26B 0% | 12.11B 66.89% | 12.11B 0% | 15.83B 30.69% | |
net income | 15.76B - | 19.82B 25.78% | 23.02B 16.13% | 24.23B 5.28% | 23.65B 2.41% | 28.31B 19.72% | 53.35B 88.45% | 26.48B 50.36% | 26.48B 0% | 31.73B 19.82% | 31.73B 0% | 34.86B 9.86% | |
weighted average shs out | 583.52M - | 584.16M 0.11% | 585.21M 0.18% | 585.88M 0.11% | 585.91M 0.00% | 585.91M 0% | 585.94M 0.01% | 585.94M 0% | 585.94M 0% | 585.85M 0.01% | 585.85M 0% | 582.83M 0.52% | |
weighted average shs out dil | 583.77M - | 584.32M 0.09% | 585.22M 0.15% | 585.89M 0.11% | 585.94M 0.01% | 585.94M 0% | 585.94M 0.00% | 585.94M 0% | 585.94M 0% | 585.85M 0.01% | 585.94M 0.01% | 582.83M 0.53% | |
eps | 27.03 - | 34.67 28.26% | 39.33 13.44% | 41.36 5.16% | 40.36 2.42% | 40.36 0% | 91.05 125.59% | 45.19 50.37% | 45.20 0.02% | 54.16 19.82% | 54.16 0% | 59.81 10.43% | |
epsdiluted | 27 - | 34.66 28.37% | 39.33 13.47% | 41.36 5.16% | 40.36 2.42% | 40.36 0% | 91.05 125.59% | 45.19 50.37% | 45.20 0.02% | 54.16 19.82% | 54.15 0.02% | 59.81 10.45% |
All numbers in INR (except ratios and percentages)